Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Tang

Showing results (691-700 of 869) with videos related to

Pageof 87
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINTSaeid Mirzai, Ian Persits, Richard Kazibwe, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Scientific Reports|July 2, 2025
Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of AtherosclerosisMatthew J Budoff, Marcia C de Oliveira Otto, Xinmin S Li, et al.
Journal of Cardiac Failure|February 27, 2018
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical TrialsMichael S Kiernan, Susanna R Stevens, W H Wilson Tang, et al.
European Radiology|December 20, 2023
Quantitative metrics of the LV trabeculated layer by cardiac CT and cardiac MRI in patients with suspected noncompaction cardiomyopathyAshish Manohar, Davis M Vigneault, Deborah H Kwon, et al.
Annals of the American Thoracic Society|March 20, 2013
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 yearErika L Lundgrin, Margaret M Park, Jacqueline Sharp, et al.
European Journal of Heart Failure|January 3, 2019
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of CardiologyWilfried Mullens, Kevin Damman, Veli-Pekka Harjola, et al.
JCI Insight|August 18, 2017
Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trialSamar Farha, Didem Saygin, Margaret M Park, et al.
Circulation. Heart Failure|January 30, 2025
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisW H Wilson Tang, Yuxi Liu, Javed Butler, et al.
Journal of Molecular and Cellular Cardiology|June 6, 2013
miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patientsManveen K Gupta, Carmel Halley, Zhong-Hui Duan, et al.
Pageof 87

Showing results (691-700 of 869) with videos related to

Sort By:
Pageof 87
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINTSaeid Mirzai, Ian Persits, Richard Kazibwe, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Scientific Reports|July 2, 2025
Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of AtherosclerosisMatthew J Budoff, Marcia C de Oliveira Otto, Xinmin S Li, et al.
Journal of Cardiac Failure|February 27, 2018
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical TrialsMichael S Kiernan, Susanna R Stevens, W H Wilson Tang, et al.
European Radiology|December 20, 2023
Quantitative metrics of the LV trabeculated layer by cardiac CT and cardiac MRI in patients with suspected noncompaction cardiomyopathyAshish Manohar, Davis M Vigneault, Deborah H Kwon, et al.
Annals of the American Thoracic Society|March 20, 2013
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 yearErika L Lundgrin, Margaret M Park, Jacqueline Sharp, et al.
European Journal of Heart Failure|January 3, 2019
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of CardiologyWilfried Mullens, Kevin Damman, Veli-Pekka Harjola, et al.
JCI Insight|August 18, 2017
Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trialSamar Farha, Didem Saygin, Margaret M Park, et al.
Circulation. Heart Failure|January 30, 2025
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisW H Wilson Tang, Yuxi Liu, Javed Butler, et al.
Journal of Molecular and Cellular Cardiology|June 6, 2013
miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patientsManveen K Gupta, Carmel Halley, Zhong-Hui Duan, et al.
Pageof 87